跳至主要内容
临床试验/CTRI/2021/04/032782
CTRI/2021/04/032782已完成不适用

Prevalence of frailty and its effect on requirement of organ support and clinical outcomes in critically ill patients

Depaartment Of Anaesthesia and Intensive Care1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年4月15日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Prevalence of frailty

研究概览

简要总结

Frailty is a newer concept of assessing a patient’s vulnerability to adverse clinical outcomes taking into account the clinical and sociodemographic factors. It has got a multifactorial etiology that may help to identify vulnerable patients in various healthcare settings. The present study is intended to find out the prevalence of frail patients in critical care settings . The patients of age more than 13 years that are admitted to main intensive care unit of PGIMER, Chandigarh will be divided into two groups depending on the score of 5 on Clinical Frailty Scale(CFS). The frail group of patients having CFS more than or equal to 5 will be compared to non-frail patients  with CFS less than 5. The primary outcome of the study is to find out the prevalence of frailty in critically ill patients. The secondary aim will be to compare the two groups on  the requirement of organ support therapies as well as other variables e.g. ICU and Hospital mortality, ICU and Hospital length of stay, Hospital acquired infection and 30 days mortality.

研究设计

研究类型
Observational

入排标准

年龄范围
13.00 Year(s) 至 95.00 Year(s)(—)
性别
All

入选标准

  • Patients getting admitted to Main Intensive Care Unit.

排除标准

  • Death within 24 hours of ICU admission
  • Admission for palliation and organ donation
  • Patient could not be interviewed and proxy not available
  • Patients leaving against medical advice.

结局指标

主要结局

Prevalence of frailty

时间窗: Within 24 hour of admission to ICU

次要结局

  • Mechanical ventilation(Vasoactive support)

研究者

发起方
Depaartment Of Anaesthesia and Intensive Care
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验

Prevalence of frailty in patients getting admitted... | 临床试验